BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
JA Silver, M Bogatchenko… - … -Head & Neck …, 2021 - journals.sagepub.com
… In this study, BRAF V600E mutation was associated with aggressive disease in small
papillary thyroid carcinoma ≤ 1.5 cm and papillary thyroid microcarcinoma ≤ 1 cm, defined by: …
papillary thyroid carcinoma ≤ 1.5 cm and papillary thyroid microcarcinoma ≤ 1 cm, defined by: …
[HTML][HTML] Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies
… BRAF mutation in thyroid cancer occurs only in PTC and PTC-derived anaplastic … that tumors
with BRAF V600E mutation were almost twice as likely (RR = 1.79) as those with BRAF wild-…
with BRAF V600E mutation were almost twice as likely (RR = 1.79) as those with BRAF wild-…
[HTML][HTML] Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis
C Liu, T Chen, Z Liu - World journal of surgical oncology, 2016 - Springer
… meta-analysis to evaluate the associations between the BRAF V600E mutation status and
aggressive clinicopathological features and poor prognostic factors in papillary thyroid cancer. …
aggressive clinicopathological features and poor prognostic factors in papillary thyroid cancer. …
[HTML][HTML] Papillary thyroid cancer—Aggressive variants and impact on management: A narrative review
A Coca-Pelaz, JP Shah, JC Hernandez-Prera… - Advances in …, 2020 - Springer
… good survival despite the aggressive clinical presentation. BRAF mutation has also been …
However, the reported rates of BRAF mutation vary significantly between studies. Lee et al. […
However, the reported rates of BRAF mutation vary significantly between studies. Lee et al. […
[HTML][HTML] BRAF V600E mutation correlates with aggressive clinico-pathological features but does not influence tumor recurrence in papillary thyroid carcinoma—10 …
… the aggressive tumor behavior of BRAF+ PTC. The question arises whether BRAF mutation
plays a role as a prognostic marker, and how we should deal with BRAF+ tumors. This issue …
plays a role as a prognostic marker, and how we should deal with BRAF+ tumors. This issue …
… of BRAF gene mutation in thyroid tumors: Significant association with papillary tumors and extra thyroidal extension indicating its role as a biomarker of aggressive …
… In the current study, 95 specimens of thyroid tumors were subjected to BRAF mutation
analysis. The clinicopathological findings of all the specimen is presented in Table-1. The median …
analysis. The clinicopathological findings of all the specimen is presented in Table-1. The median …
[HTML][HTML] Genetic profiles of aggressive variants of papillary thyroid carcinomas
M Jin, DE Song, J Ahn, E Song, YM Lee, TY Sung… - Cancers, 2021 - mdpi.com
… In PTC, TERT promoter mutation was more frequent in BRAF mutated tumors [31], which is
… promoter mutations, five (83.3%) had a coexisting BRAF mutation. TP53, a tumor suppressor …
… promoter mutations, five (83.3%) had a coexisting BRAF mutation. TP53, a tumor suppressor …
Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status
C Means, DR Clayburgh, L Maloney, D Sauer… - Head & …, 2019 - Wiley Online Library
… correlate with BRAF V600E mutation status,16, 25 however, our data did not corroborate
this. Additionally, BRAF V600E mutation status was not found to be associated with aggressive …
this. Additionally, BRAF V600E mutation status was not found to be associated with aggressive …
[HTML][HTML] Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
C Yan, M Huang, X Li, T Wang… - Endocrine connections, 2019 - ec.bioscientifica.com
… for BRAF V600E mutation. The presence of BRAF V600E mutation is not an aggressive …
lack of correlation between BRAF V600E mutation and either aggressive clinicopathological …
lack of correlation between BRAF V600E mutation and either aggressive clinicopathological …
Combined effect of Hashimoto's thyroiditis and BRAFV600E mutation status on aggressiveness in papillary thyroid cancer
… thyroiditis and BRAF V600E mutation status in patients with papillary thyroid cancer (PTC)
and … Hashimoto's thyroiditis and BRAF V600E mutation status influence PTC aggressiveness. …
and … Hashimoto's thyroiditis and BRAF V600E mutation status influence PTC aggressiveness. …
相关搜索
- papillary thyroid carcinoma braf mutation status
- papillary thyroid carcinomas braf overexpression
- thyroid carcinoma braf v600e mutation analysis
- papillary thyroid carcinoma tall cell variant
- papillary thyroid carcinoma chinese population
- patients with papillary thyroid carcinoma
- immune landscape papillary thyroid cancer
- papillary thyroid carcinoma clinical features
- aggressive variants of papillary thyroid carcinoma
- papillary thyroid carcinomas tert promoter mutations
- brafv600e mutation classic papillary thyroid cancer
- papillary thyroid carcinoma oncogenic mutations
- papillary thyroid carcinoma histopathological aggressiveness
- thyroid cancer braf v600e mutation status
- brafv600e mutation status papillary thyroid cancer
- hobnail variant of papillary thyroid carcinoma